EP422: Some Indie Pharmacy Upshots That Surprised Meand I Thought I Was Pretty in the Know, With Benjamin Jolley, PharmD

Published: Jan. 4, 2024, 11:30 a.m.

Episode 422: The Financial Struggles and Unexpected Insights of Independent Pharmacies with Benjamin Jolley

To read the full article and show notes with links mentioned as well as a full transcript, click here.

In this episode, Stacey Richter interviews Benjamin Jolley, a multi-generational pharmacy leader and consultant, who discusses the financial challenges faced by independent pharmacies. Jolley reveals that a significant portion of a pharmacy's profits comes from a mere 10% of prescriptions. The conversation dives into the detrimental impact of Pharmacy Benefit Managers (PBMs) on pricing and reimbursement, the inefficiencies in the system, and explores potential models like direct pharmacy care to create more sustainable business practices. The discussion also touches on the broader implications for local communities and the healthcare system overall.

Love the show? Please consider signing up for our weekly newsletter. We'll send you an article covering the latest episode with show notes, mentioned links and a transcribed intro. Join the RHV Tribe.

04:47 Benjamin Jolley\u2019s recent revelation.

06:14 What are the 10% of drugs that provide all the profit for pharmacies?

09:21 What\u2019s happening with the other 90% of drugs that pharmacies are filling?

11:05 What is the breakdown of costs when fulfilling prescriptions and running a pharmacy?

18:50 EP379 with AJ Loiacono.

21:42 What is the \u201ccost savings\u201d within the \u201cinsane system\u201d of PBMs not sharing profit with independent pharmacies?

23:00 What is one of the things that PBMs and pharmacies don\u2019t often talk about?

26:39 What can employers do so that patients aren\u2019t getting overcharged by PBMs?

27:51 \u201cHow do I make the PBMs irrelevant?\u201d

33:30 What\u2019s the difference between an independent pharmacy delivery service and a service like Express Scripts?

34:36 What\u2019s the other potential solution in solving the problems independent pharmacies face, and why does Benjamin Jolley feel that it\u2019s not the best solution to pursue?